J&J fights opioid ‘kingpin’ label by noting 1% market share
Bloomberg Law: Andrew Pollis, professor of law, discussed whether Johnson & Johnson could be seen as liable in Oklahoma’s opioid case after the company argued it only accounted for 1% of the state’s market.
